Investors

  • Altro Health secures US$7m to bring peptides and hormone therapy to wellness businesses

    Altro Health has raised US$7m to develop its platform for wellness businesses offering clinician-prescribed medicines, peptides and laboratory testing. The company provides software that allows personal trainers, gyms and medical spas to offer services including peptides, GLP-1 medicines, hormone therapy and blood testing under their own brands. Altro handles the clinical side of the service, [...]

  • WhiteLab Genomics secures €23.2m Series B

    WhiteLab Genomics has raised €23.2m to expand in vivo testing of AI-designed genomic medicines and grow its international partnerships. The Paris-based biotechnology company closed the Series B round to support further development and validation of technologies designed through its AI platform. WhiteLab develops AI tools to design and optimise building blocks used in genomic medicines. [...]

  • Denmark’s Breye Therapeutics secures €67.5 million to advance retinal disease therapies

    Breye Therapeutics has raised €67.5m to advance its retinal disease pipeline, including a Phase 2 trial of danegaptide in diabetic retinopathy. The Danish clinical-stage biopharmaceutical company closed an oversubscribed Series A financing round to support development of its oral therapies for retinal diseases. Its lead candidate, danegaptide, is being developed as an oral treatment for [...]

  • Inovus Medical funding reaches £15m for expansion

    Inovus Medical has taken its total funding to US$20m (£15m) as the St Helens surgical training firm expands internationally.

  • Corridor raises US$25m to bring AI-powered health benefits to small businesses

    Corridor has raised US$25m in seed funding for its AI health benefits service for small employers, combining human advisers with automated support. The New York startup uses AI agents to handle repetitive administrative tasks linked to health benefits while retaining human advisers. Its technology can check whether a doctor is included in an insurance plan's [...]

  • Cardiac AI startup UltraSight secures US$24 million for US expansion

    UltraSight has raised US$24m to expand its AI-guided cardiac ultrasound platform across US hospitals and develop intensive care and circulatory support workflows. The Israeli company said the Series B2 financing will support wider adoption of its Echosystem platform in the US and the development of additional tools for clinical settings where rapid imaging can directly [...]

  • AI agent startup Health Force raises €4.2 million

    Health Force has raised €4.2m in Seed funding to expand its hospital AI agents into more workflows and grow its engineering and delivery teams. The Barcelona-based health tech company develops AI agents designed to automate administrative and operational tasks in hospitals. Founded in Vienna in 2022 by Fadi Haddad and Dr Juan Suárez, Health Force [...]

  • Health benefits platform Thatch reaches US$1B valuation

    Thatch has raised US$108m at a US$1bn valuation for its healthcare benefits platform for employers and workers. The new funding comes 17 months after the company raised a US$40m Series B at a US$410m valuation, according to PitchBook. Thatch co-founder and chief executive Chris Ellis said the company had increased its annual recurring revenue about [...]

  • Aeon extends seed round to €12 million and acquires Aware Health

    Aeon has extended its seed funding to more than €12m and acquired German blood diagnostics platform Aware Health. As reported by EU-Startups, the Zurich-based company previously raised €8.2m in June 2025. Aeon combines whole-body magnetic resonance imaging (MRI), blood diagnostics and genetic risk analysis with AI designed to identify health trends and predict individual risks. [...]

  • Bristol uni spinout raises £700k for vascular disease blood test

    A University of Bristol University spinout has launched with more than £700,000 of pre-seed funding to develop a blood test for detecting and monitoring microvascular disease. Dimension Technologies' novel blood test aims identify biochemical signs of disease in the microvasculature, the network of microscopic blood vessels that delivers oxygen and nutrients throughout the body. Damage [...]